Tag: Johns Hopins University

You may have seen the news this week about the latest “cure” for Parkinson’s Disease.

“A cure may be on the horizon for Parkinson’s as scientists have found an experimental drug can slow down its progression and stop symptoms.

NLY01 has been called ‘amazingly protective’ as preliminary trials showed it blocked brain cells from dying.”

Researchers at Johns Hopkins University are optimistic that the drug NLY01 will go to clinical trials on humans later this year. The drug, which is similar to those used to treat diabetes, was able to slow Parkinson’s progression and ease symptoms in mouse trials. We have been hearing a lot in the last few years about repurposing diabetes medications for Parkinson’s Disease, so this new drug trial seems to be a logical next step in the development of a drug specifically for PD.

Should you go out and scream from the mountain tops that the cure has been found? Probably not yet. But this trial gives us reason to be cautiously optimistic. Researchers are investigating so many different angles to delaying or stopping the disease, that at least one of them may just be what we have been waiting for.

Will NLY01 work for everyone with PD, no matter what stage they are in? That is a question that still needs to be answered with the upcoming clinical trials. But if this new drug can really stop PD in its tracks for those who have been newly diagnosed, it will be a game changer. While Parkies have already shown that we can lead productive, healthy and long lives, if NYL01 actually delivers on its potential, it could make that better, easier and who knows, maybe even cheaper.

Fingers crossed (or whatever works for you); we’ll just have to wait and see.

Spread the word

Like this:

LikeLoading...

Follow Me on Wordpress

Disclaimer

Dear Readers: I love to see your comments and get your emails as we share our collective experiences. I am just a lay person and a patient like the rest of you. For medical and similar advice, you need to talk to your own doctors.